Display options
Cite
Prasad AR, Prasad S, Nguyen H, et al. Novel diet-related mouse model of colon cancer parallels human colon cancer. World J Gastrointest Oncol. 2014;6(7):225-43doi: 10.4251/wjgo.v6.i7.225.
Prasad, A. R., Prasad, S., Nguyen, H., Facista, A., Lewis, C., Zaitlin, B., Bernstein, H., & Bernstein, C. (2014). Novel diet-related mouse model of colon cancer parallels human colon cancer. World journal of gastrointestinal oncology, 6(7), 225-43. https://doi.org/10.4251/wjgo.v6.i7.225
Prasad, Anil R, et al. "Novel diet-related mouse model of colon cancer parallels human colon cancer." World journal of gastrointestinal oncology vol. 6,7 (2014): 225-43. doi: https://doi.org/10.4251/wjgo.v6.i7.225
Prasad AR, Prasad S, Nguyen H, Facista A, Lewis C, Zaitlin B, Bernstein H, Bernstein C. Novel diet-related mouse model of colon cancer parallels human colon cancer. World J Gastrointest Oncol. 2014 Jul 15;6(7):225-43. doi: 10.4251/wjgo.v6.i7.225. PMID: 25024814; PMCID: PMC4092339.
Copy Download .nbib Format: NLM
Share it on

World J Gastrointest Oncol. 2014 Jul 15;6(7):225-43. doi: 10.4251/wjgo.v6.i7.225.

Novel diet-related mouse model of colon cancer parallels human colon cancer.

World journal of gastrointestinal oncology

Anil R Prasad, Shilpa Prasad, Huy Nguyen, Alexander Facista, Cristy Lewis, Beryl Zaitlin, Harris Bernstein, Carol Bernstein

Affiliations

  1. Anil R Prasad, Department of Pathology, Northwest Medical Center, Tucson, AZ 85741, United States.

PMID: 25024814 PMCID: PMC4092339 DOI: 10.4251/wjgo.v6.i7.225

Abstract

AIM: To investigate the close parallels between our novel diet-related mouse model of colon cancer and human colon cancer.

METHODS: Twenty-two wild-type female mice (ages 6-8 wk) were fed the standard control diet (AIN-93G) and an additional 22 female mice (ages 6-8 wk) were fed the control diet supplemented with 0.2% deoxycholic acid [diet + deoxycholic acid (DOC)] for 10 mo. Tumors occurred in the colons of mice fed diet + DOC and showed progression to colon cancer [adenocarcinoma (AC)]. This progression is through the stages of tubular adenoma (TA), TA with high grade dysplasia or adenoma with sessile serrated morphology, intramucosal AC, AC stage T1, and AC stage T2. The mouse tumors were compared to human tumors at the same stages by histopathological analysis. Sections of the small and large intestines of mice and humans were evaluated for glandular architecture, cellular and nuclear morphology including cellular orientation, cellular and nuclear atypia, pleomorphism, mitotic activity, frequency of goblet cells, crypt architecture, ulceration, penetration of crypts through the muscularis mucosa and presence of malignant crypts in the muscularis propria. In addition, preserved colonic tissues from genetically similar male mice, obtained from a prior experiment, were analyzed by immunohistochemistry. The male mice had been fed the control diet or diet + DOC. Four molecular markers were evaluated: 8-OH-dG, DNA repair protein ERCC1, autophagy protein beclin-1 and the nuclear location of beta-catenin in the stem cell region of crypts. Also, male mice fed diet + DOC plus 0.007% chlorogenic acid (diet + DOC + CGA) were evaluated for ERCC1, beclin-1 and nuclear location of beta-catenin.

RESULTS: Humans with high levels of diet-related DOC in their colons are at a substantially increased risk of developing colon cancer. The mice fed diet + DOC had levels of DOC in their colons comparable to that of humans on a high fat diet. The 22 mice without added DOC in their diet had no colonic tumors while 20 of the 22 mice (91%) fed diet + DOC developed colonic tumors. Furthermore, the tumors in 10 of these mice (45% of mice) included an adenocarcinoma. All mice were free of cancers of the small intestine. Histopathologically, the colonic tumor types in the mice were virtually identical to those in humans. In humans, characteristic aberrant changes in molecular markers can be detected both in field defects surrounding cancers (from which cancers arise) and within cancers. In the colonic tissues of mice fed diet + DOC similar changes in biomarkers appeared to occur. Thus, 8-OH-dG was increased, DNA repair protein ERCC1 was decreased, autophagy protein beclin-1 was increased and, in the stem cell region at the base of crypts there was substantial nuclear localization of beta-catenin as well as increased cytoplasmic beta-catenin. However, in mice fed diet + DOC + CGA (with reduced frequency of cancer) and evaluated for ERCC1, beclin-1, and beta-catenin in the stem cell region of crypts, mouse tissue showed amelioration of the aberrancies, suggesting that chlorogenic acid is protective at the molecular level against colon cancer. This is the first diet-related model of colon cancer that closely parallels human progression to colon cancer, both at the histomorphological level as well as in its molecular profile.

CONCLUSION: The diet-related mouse model of colon cancer parallels progression to colon cancer in humans, and should be uniquely useful in model studies of prevention and therapeutics.

Keywords: 8-OH-dG; Beclin 1; Beta-catenin; Chlorogenic acid; Colon cancer; Deoxycholate; Diet; Histology; Mouse model

References

  1. Nucleic Acids Res. 2012 Aug;40(14):e107 - PubMed
  2. Science. 2013 Mar 29;339(6127):1546-58 - PubMed
  3. Biosci Biotechnol Biochem. 1999 Jul;63(7):1295-7 - PubMed
  4. Genetics. 1998 Apr;148(4):1491-505 - PubMed
  5. Chem Res Toxicol. 2011 Nov 21;24(11):1876-81 - PubMed
  6. Eur J Cancer Prev. 2004 Apr;13(2):127-32 - PubMed
  7. Br J Nutr. 1998 Jun;79(6):495-500 - PubMed
  8. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009 Apr;27(2):120-39 - PubMed
  9. Nature. 2001 Feb 15;409(6822):860-921 - PubMed
  10. Eur J Cancer. 2005 Sep;41(13):1911-22 - PubMed
  11. J Pathol. 2001 Sep;195(2):171-8 - PubMed
  12. Am J Surg Pathol. 2009 Dec;33(12):1823-32 - PubMed
  13. Carcinogenesis. 2009 Jan;30(1):88-92 - PubMed
  14. Genetics. 2000 Mar;154(3):1291-300 - PubMed
  15. Int J Cancer. 1999 Aug 12;82(4):504-11 - PubMed
  16. Apoptosis. 2008 Sep;13(9):1162-71 - PubMed
  17. Bioessays. 2011 Mar;33(3):224-31 - PubMed
  18. J Toxicol. 2009;2009:785907 - PubMed
  19. J Clin Invest. 1986 Mar;77(3):850-9 - PubMed
  20. Am J Gastroenterol. 1999 May;94(5):1373-80 - PubMed
  21. Antioxid Redox Signal. 2014 Feb 1;20(4):708-26 - PubMed
  22. Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6982-7 - PubMed
  23. Carcinogenesis. 2002 Aug;23(8):1281-8 - PubMed
  24. Genome Integr. 2012 Apr 11;3(1):3 - PubMed
  25. Gastroenterology. 2005 May;128(5):1160-71 - PubMed
  26. Nature. 2010 Jan 14;463(7278):191-6 - PubMed
  27. J Clin Invest. 1968 Sep;47(9):2070-8 - PubMed
  28. Mutat Res. 1990 May;238(3):313-20 - PubMed
  29. Gastroenterology. 2010 Mar;138(3):834-42 - PubMed
  30. World J Gastroenterol. 2009 Jul 21;15(27):3329-40 - PubMed
  31. Ann N Y Acad Sci. 2012 Sep;1267:110-6 - PubMed
  32. Carcinogenesis. 2002 Dec;23(12):2063-80 - PubMed
  33. Gut. 2001 Dec;49(6):835-42 - PubMed
  34. Arch Toxicol. 2011 Aug;85(8):863-71 - PubMed
  35. Nutr Cancer. 2012;64(1):34-40 - PubMed
  36. Mech Ageing Dev. 1996 Nov 13;91(3):211-8 - PubMed
  37. Gut. 2005 Jun;54(6):797-802 - PubMed
  38. Carcinogenesis. 2009 Feb;30(2):183-96 - PubMed
  39. Carcinogenesis. 2004 May;25(5):681-92 - PubMed
  40. Oncogene. 2012 Jan 19;31(3):342-51 - PubMed
  41. Carcinogenesis. 2007 Jan;28(1):215-22 - PubMed
  42. CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 - PubMed
  43. Nutr Cancer. 1990;14(1):5-13 - PubMed
  44. J Nutr. 1980 Sep;110(9):1880-7 - PubMed
  45. Semin Cancer Biol. 2013 Oct;23(5):361-79 - PubMed
  46. PLoS Genet. 2007 Jul;3(7):e110 - PubMed
  47. PLoS Genet. 2008 Aug 15;4(8):e1000155 - PubMed
  48. Free Radic Res. 2012 Apr;46(4):420-41 - PubMed
  49. Science. 2010 Apr 30;328(5978):636-9 - PubMed
  50. J Vis Exp. 2010 Jul 28;(41): - PubMed
  51. Nat Genet. 2012 Nov;44(11):1277-81 - PubMed
  52. J Agric Food Chem. 2002 Jun 19;50(13):3660-7 - PubMed
  53. Cancer J. 2010 May-Jun;16(3):196-201 - PubMed
  54. Ethn Dis. 2004 Summer;14(3):431-9 - PubMed

Publication Types

Grant support